• Explore /
  • Poster
  • / Biomarker-oriented study of pembrolizumab in combination with chemotherapy in chemotherapy-naïve advanced pancreatic cancer: A phase 2 trial-in-progress.

Biomarker-oriented study of pembrolizumab in combination with chemotherapy in chemotherapy-naïve advanced pancreatic cancer: A phase 2 trial-in-progress.

Abstract Poster

Authors

null

Jeesun Yoon

Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea

Jeesun Yoon , Jin Won Kim , Ji-Won Kim , Tae-Yong Kim , Ah-Rong Nam , Ju-Hee Bang , Jae-Min Kim , Kyoung Seok Oh , Do-Youn Oh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT04447092

DOI

10.1200/JCO.2022.40.4_suppl.TPS639

Abstract #

TPS639

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Gulam Abbas Manji

First Author: Vincent Chung

First Author: Valerie Lee

First Author: Valerie Lee